| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Bloom Energy (BE) | J.P. Morgan/ Morgan Stanley/ Credit Suisse/ KeyBanc Capital Markets/ BofA Merrill Lynch | $100.00 | n.a. | |||
| Navios Maritime Containers L.P. (TBA) | J.P. Morgan/ BofA Merrill Lynch/ Citigroup/ Clarksons Platou Securities | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| Postponed | ||||||
| M17 Entertainment Limited (YQ) | Citigroup/ Deutsche Bank Securities | 7.51 | $8.00 | $8.00 | $60.09 | n.a. |
| Withdrawn | ||||||
| Adaptive Insights (ADIN) | Morgan Stanley/ BoA Merrill Lynch/ Jefferies/ RBC Capital Markets | 8.20 | $13.00 | $15.00 | $114.80 | n.a. |
| New Terms | ||||||
| AVROBIO (AVRO) | Morgan Stanley/ Cowen/ Wells Fargo Securities | 4.41 | $16.00 | $18.00 | $75.00 | S/O |
| Aptinyx (APTX) | J.P. Morgan/ Cowen/ Leerink Partners/ BMO Capital Markets | 5.33 | $14.00 | $16.00 | $80.00 | S/O |
| Electrocore (ECOR) | Evercore ISI/ JMP Securities | 4.33 | $14.00 | $16.00 | $65.00 | S/O |
| Entera Bio Ltd. (ENTX) | Maxim Group | 1.33 | $8.00 | $10.00 | $12.00 | S/O |
| Essential Properties Realty Trust (EPRT) | Goldman Sachs/ Citigroup/ Barclays | 32.50 | $14.00 | $17.00 | $503.75 | S/O |
| HL Acquisitions (HCCHU) (u) | EarlyBirdCapital | 4.25 | $10.00 | $10.00 | $42.50 | S/O |
| i3 Verticals (IIIV) | Cowen/ Raymond James/ KeyBanc Capital Markets | 6.65 | $11.00 | $13.00 | $79.80 | S/O |
| LF Capital Acquisition (LFACU) (u) | B. Riley FBR/ Raymond James | 13.50 | $10.00 | $10.00 | $135.00 | S/O |
| Neon Therapeutics (NTGN) | Morgan Stanley/ BofA Merrill Lynch/ Mizuho Securities | 6.25 | $15.00 | $17.00 | $100.00 | S/O |
| Neuronetics (STIM) | Piper Jaffray/ William Blair | 5.00 | $14.00 | $16.00 | $75.00 | S/O |
| Twelve Seas Investment (TWLVU) (u) | EarlyBirdCapital | 15.00 | $10.00 | $10.00 | $150.00 | S/O |
| Uxin Limited (UXIN) | Morgan Stanley/ Goldman Sachs (Asia)/ J.P. Morgan/ CICC/ China Renaissance | 38.00 | $10.50 | $12.50 | $437.00 | S/O |
| Xeris Pharmaceuticals (XERS) | Jefferies/ Leerink Partners/ RBC Capital Markets | 5.00 | $14.00 | $16.00 | $75.00 | S/O |
| S/O (Subscribers Only) | ||||||
| u (unit offering) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of June 11, 2018 | Manager(s) | Offered | Raised | Price | 6/15/18 | Change |
| Avalara (AVLR) | Goldman Sachs/ J.P. Morgan Securities/ BofA Merrill Lynch | 7.50 | $180.00 | $24.00 | $44.94 | 87.25% |
| Puxin Ltd. (NEW) | Citigroup/ Deutsche Bank Securities/ Barclays/ Haitong International/ CICC | 7.20 | $122.40 | $17.00 | $21.00 | 23.53% |
| Verrica Pharmaceuticals (VRCA) | BofA Merrill Lynch/ Jefferies/ Cowen | 5.00 | $75.00 | $15.00 | $17.50 | 16.67% |
| U.S. Xpress Enterprises (USX) | BofA Merrill Lynch/ Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities | 18.06 | $288.90 | $16.00 | $16.62 | 3.88% |
| Far Point Acquisition (FPAC.U) (u) | Credit Suisse/ BofA Merrill Lynch | 55.00 | $550.00 | $10.00 | $10.20 | 2.00% |
| Charah Solutions (CHRA) | Morgan Stanley/ BoA Merrill Lynch/ Stife | 7.35 | $88.24 | $12.00 | $11.70 | -2.50% |
| u (unit offering) | ||||||
